Aveva Drug Delivery Systems has received permission from the Food and Drug Administration for its generic lidocaine 1.8% patch, a non-opioid topical treatment for post-herpetic neuralgia. The generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback